Atlas FDA

EUFLEXXA (1% SODIUM HYALURONATE)

FDA premarket approval P010029/S016 · decided 2013-03-13

Approval details

PMA number
P010029
Supplement
S016
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
EUFLEXXA (1% SODIUM HYALURONATE)
Generic name
Acid, hyaluronic, intraarticular
Applicant
Ferring Pharmaceuticals, Inc.
Date received
2013-01-15
Decision date
2013-03-13
Days to decision
57 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Parsippany, NJ
Statement
CHANGE IN THE CLASSIFICATION OF A MATERIALS WEIGHING ROOM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.